✦ LIBER ✦
A phase III randomized, doúble-blind, multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma
✍ Scribed by Marc K. Wallack; Muthukumaran Sivanandham; Charles M. Balch; Marshall M. Urist; Kirby I. Bland; Douglas Murray; William A. Robinson; Lawrence E. Flaherty; Jon M. Richards; Alfred A. Bartolucci; Les Rosen
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 876 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.